Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that its Board of Directors (the "Board") has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock (the "Reverse Stock Split"). The Board received approval at the Company's Annual Meeting of Stockholders on June 12, 2026 to approve and adopt an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock.

The Reverse Stock Split will become effective at 12:01 a.m. EDT on July 1, 2026. The Company's common stock will continue to trade under the symbol "RMTI" on the Nasdaq Capital Market. The new CUSIP number following the Reverse Stock Split will be 774374409.